Advanced Search

Innate Immunity Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

SECTION HEADS

  • Photo of Alan Ezekowitz

    Alan Ezekowitz

    Laboratory of Developmental Immunology, Merck & Co Inc., Whitehouse Station, NJ, USA

  • Photo of Jules Hoffmann

    Jules Hoffmann

    Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, MO, USA

  • Photo of Dieter Kabelitz

    Dieter Kabelitz

    Institute of Immunology, University Clinic Schleswig-Holstein, Kiel, Germany

  • Photo of David Raulet

    David Raulet

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA

Section Topics

  • » Basophil
  • » Complement
  • » Eosinophils
  • » Inflammation & mediators
  • » Innate Immunity in lower organisms
  • » Innate immunity
  • » Intracellular killing
  • » Killer cells & killing mechanisms
  • » NK cells
  • » Neutrophils
  • » Opsonization
  • » Phagocytosis/scavenging

LATEST EVALUATION

This interesting publication reports the characterization of a new mouse model to follow follicular helper T (Tfh) cells during immune responses. To generate a faithful reporter mouse, the authors introduced a green fluorescent...

Jens V Stein, Universität Bern, Switzerland. F1000 Immunology

8 Must Read

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

14
The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response.

Sanada T, Kim M, Mimuro H, Suzuki M, ..., Gohda J, Inoue J, Mizushima T, Sasakawa C. Nature. 2012 Mar 29; 483(7391):623-6

4 Evaluations, most recent by

Christoph Dehio and Arto Pulliainen, University of Basel, Switzerland. F1000 Microbiology

  • New Finding
  • Good for Teaching
  • Novel Drug Target

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

Faculty of 1000